Enzo Biochem Inc
NYSE:ENZ
Enzo Biochem Inc
Cash from Operating Activities
Enzo Biochem Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Enzo Biochem Inc
NYSE:ENZ
|
Cash from Operating Activities
-$44.4m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-16%
|
|
DaVita Inc
NYSE:DVA
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Operating Activities
$1.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Operating Activities
$10.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
Cigna Corp
NYSE:CI
|
Cash from Operating Activities
$11.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
26%
|
CAGR 10-Years
32%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Operating Activities
$1.2B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
See Also
What is Enzo Biochem Inc's Cash from Operating Activities?
Cash from Operating Activities
-44.4m
USD
Based on the financial report for Jan 31, 2024, Enzo Biochem Inc's Cash from Operating Activities amounts to -44.4m USD.
What is Enzo Biochem Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-16%
Over the last year, the Cash from Operating Activities growth was -79%. The average annual Cash from Operating Activities growth rates for Enzo Biochem Inc have been -58% over the past three years , -19% over the past five years , and -16% over the past ten years .